UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors - Related Studies

UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors

This study is ongoing, but not recruiting participants.

Study NCT00047242. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Interventions listed in this trial
		7-hydroxystaurosporine
		irinotecan hydrochloride

2	Additional drug interventions recognized in this trial
		Camptothecin
		Irinotecan
		Staurosporine

3	More general drug interventions related to this trial
		Antineoplastic Agents
		Antineoplastic Agents, Phytogenic
		Enzyme Inhibitors
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Protein Kinase Inhibitors
		Therapeutic Uses

4	Sponsors listed in this trial
		Sidney Kimmel Comprehensive Cancer Center
		National Cancer Institute (NCI)